In 2023 Lilly published results of its phase 2 trial for orforglipron, a once-daily oral drug which achieved up to 14.7% mean weight reduction at 36 weeks, and Pfizer has completed phase 2 trial for its oral drug danuglipron and is now optimising the formulation
LifeRx.md offers trusted, convenient access to online GLP-1 prescriptionswith personalized treatment plans, expert medical support, and fast delivery to your home
Similar to other disabling chronic illnesses, resultant depression and anxiety in ME/CFS are frequent (36) and there is a higher risk of suicide in ME/CFS (37)
Osteoporos Int 29(12):26392644 Zhang YS, Zheng YD, Yuan Y, Chen SC, Xie BC (2021) Effects of Anti-Diabetic Drugs on Fracture Risk: A Systematic Review and Network Meta-Analysis
While research is still evolving, peptides have become increasingly popular among individuals looking for ways to support mobility, healing, and overall joint function